|
Millennium Pharmaceuticals News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Millennium Pharmaceuticals News
- CubeTree Secures $8 Million in Series B Financing Led by InterWest Partners 4 Nov 2009 13:35 GMT
... (ARTC), Aspreva Pharmaceuticals (ASPV, acquired by Galenica group, SWX:GALN), Cor Therapeutics (CORR; acquired by Millennium Pharmaceuticals, MLNM), Corixa Pharmaceuticals (CRXA; acquired by GlaxoSmithKline, GSK), Coulter Pharmaceuticals (CLTR; acquired by Corixa Pharmaceuticals, ...
- NeurogesX Expands Commercial Operations Leadership Team 5 Nov 2009 13:52 GMT
... Marketing and US Commercial Lead at Bristol-Myers Squibb; Senior Director, Global Strategic Marketing at Millennium Pharmaceuticals Inc; and Vice President of Marketing at Celgene. In her role at Celgene, ...
- TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post 6 Nov 2009 12:50 GMT
... broad clinical research and operations experience within the biopharmaceutical industry, including Coley Pharmaceuticals and Millennium Pharmaceuticals. Prior to joining industry, Dr. Himes held academic positions at the National Institutes ...
- Bortezomib lymphoma drug may be effective against bone cancer in children and teens: Study 6 Nov 2009 05:40 GMT
... quickly and responds poorly to current chemotherapies. The drug, a proteasome inhibitor developed by Millennium Pharmaceuticals and Johnson & Johnson, was approved by the FDA for the treatment of ...
- Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer 6 Nov 2009 06:20 GMT
... quickly and responds poorly to current chemotherapies. The drug, a proteasome inhibitor developed by Millennium Pharmaceuticals and Johnson & Johnson, was approved by the FDA for the treatment of ...
- David Pilling: Roll up for Japan's medical mystery tour 5 Nov 2009 07:30 GMT
... Japan has to a global pharmaceutical heavyweight, has bought abroad. Last year, it for Millennium Pharmaceuticals, a Bostonian biotech with a cancer drug on sale. That deal, which made ...
- Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 5 Nov 2009 15:30 GMT
... quickly and responds poorly to current chemotherapies. The drug, a proteasome inhibitor developed by Millennium Pharmaceuticals and Johnson & Johnson, was approved by the FDA for the treatment of ...
- Takeda signs obesity deal with Amylin worth over $1 billion 2 Nov 2009 12:36 GMT
... the like, year-earlier period when the company booked charges related to the acquisition of Millennium Pharmaceuticals. Sales fell 6.4% to 755.45 billion yen, mainly due to the strength of ...
- Lex: Takeda / Amylin 2 Nov 2009 16:10 GMT
... out $8.8bn – more than 70 times prospective earnings – for US cancer specialist Millennium Pharmaceuticals last year. This time, for an initial outlay of just $75m, Takeda will ...
- Greylock Partners Announces $575 Million Venture Fund 2 Nov 2009 19:31 GMT
... Data Domain, digg, DoubleClick, Facebook, Farecast, Internet Security Systems, Ikanos, Legato, LinkedIn, Media Metrix, Millennium Pharmaceuticals, Openwave, Open Market, Pandora, Red Hat, RightNow Technologies, Success Factors, Tellabs, Trilogy, Wily ...
- Micronotes Expands Advisory Board 2 Nov 2009 20:33 GMT
... Data Domain, digg, DoubleClick, Facebook, Farecast, Internet Security Systems, Ikanos, Legato, LinkedIn, Media Metrix, Millennium Pharmaceuticals, Openwave, Open Market, Pandora, Red Hat, RightNow Technologies, Success Factors, Tellabs, Trilogy, Wily ...
- Greylock Partners Announces $575 Million Venture Fund 2 Nov 2009 20:52 GMT
... Data Domain, digg, DoubleClick, Facebook, Farecast, Internet Security Systems, Ikanos, Legato, LinkedIn, Media Metrix, Millennium Pharmaceuticals, Openwave, Open Market, Pandora, Red Hat, RightNow Technologies, Success Factors, Tellabs, Trilogy, Wily ...
- Unifying Practice Patterns Among Academic and Community Clinicians: Focus on Myeloma 30 Oct 2009 14:13 GMT
... To register for the live web simulcast, visit Supported by an educational grant from Millennium Pharmaceuticals, Inc., Centocor Ortho Biotech Services, LLC, Ortho Biotech, a division of Janssen Cilag, ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
bbc.co.uk:
healthday.com:
reuters.com: